arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Esperion Therapeutics, Inc.

ESPR

$3.19 0.00 (0.00%) at close

16 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Bearish

auto_awesome

Analytical Summary

Esperion Therapeutics, Inc. faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $663.1M

Dividend Yield —

Revenue Growth 21.3% ↘

Op. Margin 15.0% ↘

ROIC -21.7% ↘

FCF / Share $-0.06 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Jul 10, 2026.

16-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$403.13M

↑ +21.3% —

Net Income Profit after all expenses

$-22.68M

↑ +56.2% —

Operating Margin Operating profit as % of sales

15.0%

↓ -8.7% 67th

FCF / Share Free cash flow per share

$-0.06

↑ +50.8% —

Long-Term Debt Long-term obligations

$1.02M

↓ -62.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Financial Health

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Revenue Growth YoY (%)	21.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+166%)	185.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2221%)	54.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+577%)	-3.8% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-147%)	-65.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-919%)	53.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+567%)	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	60.7% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	86.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	42.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	62.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-78.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	56.2% Excellent ↑ Excellent Improving Year-over-year change in net income	75.3% Excellent ↑ Excellent Improving Year-over-year change in net income	10.4% Fair ↑ Fair Improving Year-over-year change in net income	13.2% Fair ↑ Fair Improving Year-over-year change in net income	-87.5% Weak ↓ Weak Declining Year-over-year change in net income	-47.7% Weak ↓ Weak Declining Year-over-year change in net income	51.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-20.9% Weak ↑ Weak Improving Year-over-year change in net income	-122.7% Weak ↓ Weak Declining Year-over-year change in net income	-50.6% Weak ↑ Weak Improving Year-over-year change in net income	-36.9% Weak ↑ Weak Improving Year-over-year change in net income	-39.4% Weak ↓ Weak Declining Year-over-year change in net income	-122.2% Weak ↓ Weak Declining Year-over-year change in net income	-8.5% Weak Weak Year-over-year change in net income	44.3% Excellent Excellent Year-over-year change in net income	—
FCF Growth YoY (%)	50.8% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	90.3% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	50.1% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	71.2% Excellent Excellent Year-over-year change in free cash flow	-191.4% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	74.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	61.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-20.0% Weak Weak Compound annual revenue growth over 3 years	-20.2% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	12.1% Excellent Excellent Compound annual revenue growth over 5 years	17.5% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Operating Margin (%) (%)	15.0% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	16.4% Fair ↑ Fair Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+9%)	-133.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-991%)	-237.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1686%)	-289.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2027%)	-53.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-456%)	-62.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-518%)	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	-8.8% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-5.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-147%)	-15.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-230%)	-179.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1599%)	-309.6% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2680%)	-343.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2959%)	-63.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-626%)	-65.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-646%)	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-3.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-7.2% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-116.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-231.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-336.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-37.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-48.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.46x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Return on Invested Capital (%)	-21.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	27.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	43.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	90.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	99.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-368.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-204.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-54.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-26.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	23.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	26.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	12.9% Good ↑ Good Improving Operating profit relative to total assets Optimal: > 10%	15.8% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-75.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-72.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-59.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-34.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-43.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-142.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-60.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-31.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-139.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	7.5% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-50%)	13.3% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-11%)	46.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+207%)	72.2% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+381%)	136.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+811%)	149.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+895%)	—	-255.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1800%)	-68.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-555%)	-32.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-319%)	-17.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-216%)	-27.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-282%)	-35.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-335%)	28.4% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+89%)	36.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+140%)	100.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+570%)

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-99%)	0.01x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-98%)	0.03x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	—	-0.18x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-130%)	—	—
Interest Coverage (x)	3.71x Fair ↑ Fair Improving Operating income divided by interest expense Optimal: > 5x	4.79x Fair ↑ Fair Improving Operating income divided by interest expense Optimal: > 5x	—	-3.16x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4.89x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-5.35x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.47x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7306.61x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-853.44x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-202.53x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-96.23x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-134.16x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-24.32x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.86x Weak Weak Operating income divided by interest expense Optimal: > 5x	-17.61x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-167.85M	$-144.76M	$-82.25M	$-124.78M	$-208.89M	$-304.96M	$-166.13M	$-36.97M	$-34.47M	$-37.14M	$-74.65M	$-80.81M	$-56.54M	$1.02M	$-1.57M	$-3.41M
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	-0.01x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.05x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.12x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.75x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Revenue per Share (USD)	$1.94	$1.78	$1.13	$1.14	$2.71	$8.28	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.11	$-0.28	$-2.03	$-3.52	$-9.31	$-5.23	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.06	$-0.13	$-1.31	$-2.63	$-9.13	$-3.13	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-1.45	$-2.08	$-4.41	$-4.88	$-6.81	$-3.50	$0.73	$2.95	$9.30	$10.14	$12.76	$6.57	$4.83	$-119.39	—	—
Tangible Book Value per Share (USD)	$-1.45	$-2.08	$-4.41	$-4.88	$-6.82	$-3.50	$0.73	$2.95	$9.30	$10.14	$12.76	$6.57	$4.83	$-119.39	—	—
Basic Weighted Avg Shares (shares)	207.87M	187.18M	103.11M	66.41M	28.90M	27.47M	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Working Capital (USD)	$161.76M	$91.77M	$44.84M	$154.38M	$255.62M	$251.83M	$145.63M	$78.30M	$170.78M	$197.99M	$208.77M	$101.21M	$56.42M	$-10.03M	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	$1.02M	$2.69M	$4.23M	—	$7.53M	—	—
Total Equity (USD)	$-301.96M	$-388.72M	$-454.99M	$-323.78M	$-196.94M	$-96.13M	$19.95M	$79.12M	$244.69M	$228.60M	$287.26M	$133.55M	$74.09M	$-41.36M	$-30.03M	$-19.31M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Sales/Revenue/Turnover (USD)	$403.13M	$332.31M	$116.33M	$75.47M	$78.45M	$227.55M	$148.36M	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$105.00K	$63.00K	$164.00K	$500.00K	$612.00K	$547.00K	$319.00K	$265.00K	$258.00K	$252.00K	$236.00K	$160.00K	$71.00K	$139.43K	$178.47K	—
Net Income, GAAP (USD)	$-22.68M	$-51.74M	$-209.25M	$-233.66M	$-269.11M	$-143.55M	$-97.17M	$-201.81M	$-166.99M	$-74.98M	$-49.78M	$-36.38M	$-26.09M	$-11.74M	$-10.82M	$-19.42M
Operating Cash Flow (USD)	$-13.09M	$-23.65M	$-135.49M	$-174.83M	$-263.81M	$-85.18M	$-70.34M	$-148.64M	$-131.30M	$-47.73M	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 58 quarters

Esperion Therapeutics, Inc.

Analytical Summary

16-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ESPR with peers